This study aimed to examine the apoM levels in patients with hyperlipidaemia, patients with T2DM and hyperlipidaemia, and patients with T2DM but without hyperlipidaemia through enzyme-linked immunosorbent assay (ELISA). This evidence concerns the gene APOM and type 2 diabetes mellitus.